DEN DC Business Plan Competition
Judges' Biographies

Kay L. Parry

Principal, Paperboy Ventures, LLC

--------------------------------------------------------------------------------

Kay L. Parry is a Principal at Paperboy Ventures, LLC. Prior to joining Paperboy, Kay worked at WaveCrest Laboratories, a Paperboy portfolio company, where she was Vice President, Corporate Development. Before that, she was a Vice President at Velocita Corp., a telecommunications start-up in the Washington, DC area. Kay began her career at management and strategy consulting firm Dean & Company, working with a variety of clients on a wide range of strategic and operational issues.

Kay received a BA in Government and Economics cum laude from Dartmouth College. She is currently a Director for mNemoscience and Green Earth Industries. 

Wayne Roe

Director, Celera Diagnostics
Director, In-Cube Ventures

--------------------------------------------------------------------------------

Wayne Roe has more than 30 years experience in the life sciences industry with an unparalleled track record of helping leading medical device, diagnostic, pharmaceutical and biotechnology companies develop commercially successful products. He is widely recognized as the pioneer and America’s leading expert on pharmaeconomic analysis and strategic reimbursement planning for medical innovations. Expertise in both of these areas is now a standard input to the product development process for U.S. life sciences innovators.
Mr. Roe’s hands on experience with hundreds of blockbuster innovations and his unique set of analytical skills have made him sought after advisor to leading life sciences venture capitalists and financial investors. His service on a dozen boards of directors of start up technology companies over the last decade testifies to his ability to help biomedical entrepreneurs navigate the complex phases of product development.

Mr. Roe began his industry career in the mid 1970s as Vice President for Research and Economic Policy for the medical device industry trade association, HIMA, in Washington DC (now called Advamed). He conceived and directed HIMA’s successful efforts to educate industry executives about the implication of several revolutionary insurance reimbursement policies that dramatically altered the traditional U.S. medical device marketplace. His analyses and public testimony on behalf of HIMA led to several Congressional changes in Medicare and Medicaid designed to make the programs more accommodating to new medical technology.

Mr. Roe left HIMA in 1985 to begin a 15 year consulting career that brought leading- edge pharmaeconomic, reimbursement, and commercialization strategies to both start-up and established medical innovators; culminating in the founding of the consultancy Health Technology Associates (HTA) in 1988. Mr. Roe has directed hundreds of engagements with virtually every established medical product innovator. The breadth of his work has included medical devices (laparoscopic surgery, orthopedic prosthetics, cardiovascular implants, etc.); diagnostic testing (CT, MRI, molecular diagnostics, radiopharmaceuticals, etc.); pharmaceuticals (cardiovascular drugs, oncolytics, neurotropics, immunosupressives, etc.) and biologics (EPO, TPA, GCSF, Cerazyme, Remicaid, etc.). Mr. Roe’s consulting clients have realized incremental product revenues in the tens of billions of dollars based directly on the pioneering work conducted at HTA. Moreover, Mr. Roe and his HTA colleagues educated the life sciences industry on the importance of incorporating pharmaeconomic and reimbursement considerations into all phases of product development from clinical trial design and FDA regulatory strategy, to sales force training and customer service. These considerations have become standard industry practice by 2009. 

In 1996 HTA was acquired by Corning for approximately $40 million (it survives as Covance Health Economics), and Mr. Roe turned his attention to venture investing, board service and mentoring. He currently is a General Partner at DFJ InCube Ventures, an early stage life sciences venture capital firm based in Menlo Park, CA. He is also a local Angel Investor in the Washington DC area, serving as a member of the executive committee of the Maryland Angels Council. He has served on the boards of a diverse set of life sciences start-up companies including Vidamed, United Therapeutics, Ista Pharmaceuticals, Intrapace, Zonare, Favrille, Hemaquest Pharmaceuticals, and Celera Genomics. Mr. Roe is also a member of the advisory board to the Maryland Life Sciences Incubator in Montgomery Country, MD.
 

Mark Zimmerman, MBA

Chief Revenue Officer, Envision EMI
Chairman, Nolej Studios

--------------------------------------------------------------------------------

Mark recently joined Envision EMI in the role of Chief Revenue Officer. Envision provides leadership and enrichment programs to top students the U.S. and around the world and is headquartered in the Washington, DC metro area. 

A graduate of Dartmouth, Mark began his career in technology and then moved on to strategy consulting, managing engagements for media clients such as McGraw-Hill, Time, Columbia House, BMG, and Simon & Schuster. With his background in integrating content, direct marketing, and technology in new ways to maximize customer relationships, he took a position with Reader’s Digest where he led digital technology, new product and turnaround efforts in the U.S. and abroad, becoming the head of global strategy and business development and global publisher of the company’s Young Families line of products. 
After that, he spent four years at QSP, the education arm of RDA that provides support to 30,000 schools in the U.S. and Canada annually. As the SVP of Sales and North American Operations, he revitalized QSP’s image as industry leader, resurrected the company’s failing Canadian operations, and restored swagger in the 1,000+ person sales and service force, resulting in record customer retention and profit improvement.

Prior to Envision, Mark was the Managing Partner of Z Team Media, a media and marketing consultancy that advised established and emerging publishers, content providers and direct marketers about ways to leverage digital and traditional channels. 

Well-versed in the development of change/turnaround agendas at larger media and direct marketing companies and the design of sustainable growth platforms for start-ups, Mark enjoys tossing around ideas with innovative, energetic acquaintances whenever the opportunity presents itself. His idealism and commitment carries over into his active role in community affairs, serving on the boards of a number of non-profits dedicated to serving the developmentally disabled.